165 related articles for article (PubMed ID: 35315197)
41. Specific Dermatophagoides farinae extract for canine immunotherapy.
Moya R; Ramió-Lluch L; Parody N; Brazis P; Puigdemont A; Carnés J
Vet Dermatol; 2021 Apr; 32(2):131-e29. PubMed ID: 33112005
[TBL] [Abstract][Full Text] [Related]
42. The controversial histologic classification of canine subcutaneous whorling tumours: The path to perivascular wall tumours.
Avallone G; Stefanello D; Ferrari R; Roccabianca P
Vet Comp Oncol; 2020 Mar; 18(1):3-8. PubMed ID: 31778274
[TBL] [Abstract][Full Text] [Related]
43. The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40.
Khong A; Cleaver AL; Fahmi Alatas M; Wylie BC; Connor T; Fisher SA; Broomfield S; Lesterhuis WJ; Currie AJ; Lake RA; Robinson BW
BMC Cancer; 2014 Dec; 14():969. PubMed ID: 25518732
[TBL] [Abstract][Full Text] [Related]
44. Expression of fibroblast growth factor 23 by canine soft tissue sarcomas.
Hardcastle MR; Dittmer KE
Vet Comp Oncol; 2016 Sep; 14(3):306-17. PubMed ID: 24923416
[TBL] [Abstract][Full Text] [Related]
45. An immunohistochemical study of the expression of the hypoxia markers Glut-1 and Ca-IX in canine sarcomas.
Abbondati E; Del-Pozo J; Hoather TM; Constantino-Casas F; Dobson JM
Vet Pathol; 2013 Nov; 50(6):1063-9. PubMed ID: 23628694
[TBL] [Abstract][Full Text] [Related]
46. Long-Term outcome following surgical excision of large, low to intermediate grade soft tissue sarcomas in dogs.
Davis A; Hosgood G
Aust Vet J; 2023 May; 101(5):193-199. PubMed ID: 36751015
[TBL] [Abstract][Full Text] [Related]
47. Collagen-Anchored Interleukin-2 and Interleukin-12 Safely Reprogram the Tumor Microenvironment in Canine Soft-Tissue Sarcomas.
Stinson JA; Sheen A; Momin N; Hampel J; Bernstein R; Kamerer R; Fadl-Alla B; Samuelson J; Fink E; Fan TM; Wittrup KD
Clin Cancer Res; 2023 Jun; 29(11):2110-2122. PubMed ID: 37014656
[TBL] [Abstract][Full Text] [Related]
48. Influence of WR 2721 on radiation response of canine soft tissue sarcomas.
McChesney SL; Gillette EL; Dewhirst MW; Withrow SJ
Int J Radiat Oncol Biol Phys; 1986 Nov; 12(11):1957-63. PubMed ID: 3021693
[TBL] [Abstract][Full Text] [Related]
49. Treatment of canine and feline sarcoma using MR-guided focused ultrasound system.
Antoniou A; Evripidou N; Panayiotou S; Spanoudes K; Damianou C
J Ultrasound; 2022 Dec; 25(4):895-904. PubMed ID: 35277843
[TBL] [Abstract][Full Text] [Related]
50. Dendritic cell targeting with Fc-enhanced CD40 antibody agonists induces durable antitumor immunity in humanized mouse models of bladder cancer.
Garris CS; Wong JL; Ravetch JV; Knorr DA
Sci Transl Med; 2021 May; 13(594):. PubMed ID: 34011627
[TBL] [Abstract][Full Text] [Related]
51. Adjuvant electrochemotherapy with bleomycin and cisplatin combination for canine soft tissue sarcomas: A study of 30 cases.
Spugnini EP; Vincenzi B; Amadio B; Baldi A
Open Vet J; 2019 Apr; 9(1):88-93. PubMed ID: 31086772
[TBL] [Abstract][Full Text] [Related]
52. Detection of tumor-associated antigens in sera of canine cancer patients by monoclonal antibodies generated against canine mammary carcinoma cells.
Wang J; Brunner CJ; Gangopadhyay A; Bird AC; Wolfe LG
Vet Immunol Immunopathol; 1995 Oct; 48(3-4):193-207. PubMed ID: 8578680
[TBL] [Abstract][Full Text] [Related]
53. Canine Non-Angiogenic, Non-Myogenic Splenic Stromal Sarcoma: a Retrospective Clinicopathological Analysis and Investigation of Podoplanin as a Marker of Tumour Histogenesis.
Wittenberns BM; Thamm DH; Palmer EP; Regan DP
J Comp Pathol; 2021 Oct; 188():1-12. PubMed ID: 34686271
[TBL] [Abstract][Full Text] [Related]
54. The immunotherapy of canine osteosarcoma: a historical and systematic review.
Wycislo KL; Fan TM
J Vet Intern Med; 2015; 29(3):759-69. PubMed ID: 25929293
[TBL] [Abstract][Full Text] [Related]
55. Establishment and characterization of a canine soft tissue sarcoma patient-derived xenograft model.
Frazier JP; Beirne E; Ditzler SH; Tretyak I; Casalini JR; Thirstrup DJ; Knoblaugh S; Ward JG; Tripp CD; Klinghoffer RA
Vet Comp Oncol; 2017 Sep; 15(3):754-763. PubMed ID: 26991424
[TBL] [Abstract][Full Text] [Related]
56. Telomere lengths and telomerase activity in dog tissues: a potential model system to study human telomere and telomerase biology.
Nasir L; Devlin P; Mckevitt T; Rutteman G; Argyle DJ
Neoplasia; 2001; 3(4):351-9. PubMed ID: 11571635
[TBL] [Abstract][Full Text] [Related]
57. A phase I trial of hyperthermia-induced interleukin-12 gene therapy in spontaneously arising feline soft tissue sarcomas.
Siddiqui F; Li CY; Larue SM; Poulson JM; Avery PR; Pruitt AF; Zhang X; Ullrich RL; Thrall DE; Dewhirst MW; Hauck ML
Mol Cancer Ther; 2007 Jan; 6(1):380-9. PubMed ID: 17237297
[TBL] [Abstract][Full Text] [Related]
58. Principles of treatment for soft-tissue sarcomas in the dog.
Ettinger SN
Clin Tech Small Anim Pract; 2003 May; 18(2):118-22. PubMed ID: 12831074
[TBL] [Abstract][Full Text] [Related]
59. Intra- and inter-observer agreement in histological assessment of canine soft tissue sarcoma.
Yap FW; Rasotto R; Priestnall SL; Parsons KJ; Stewart J
Vet Comp Oncol; 2017 Dec; 15(4):1553-1557. PubMed ID: 28133880
[TBL] [Abstract][Full Text] [Related]
60. A novel imaging system permits real-time in vivo tumor bed assessment after resection of naturally occurring sarcomas in dogs.
Eward WC; Mito JK; Eward CA; Carter JE; Ferrer JM; Kirsch DG; Brigman BE
Clin Orthop Relat Res; 2013 Mar; 471(3):834-42. PubMed ID: 22972654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
